36C10G25R0037.docx

Combined Synopsis/Solicitation Notice

GENERAL INFORMATION

OPAL | Strategic Acquisition Center

10300 Spotsylvania Ave | STE 400 Fredericksburg VA 22408-2697

POINT OF CONTACT*

Contract Specialist/Contracting Officer Kristal Hall kristal.hall@va.gov 240-917-9690

PLACE OF PERFORMANCE

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

DESCRIPTION

Combined Synopsis/Solicitation Notice

Solicitation Number:

36C10G25R0037 Notice Type:

Combined Synopsis/Solicitation Synopsis:

COMBINED SYNOPSIS/SOLICITATION

This is a combined synopsis/solicitation for brand name or equal commercial products prepared in accordance with (IAW) the format in Federal Acquisition Regulation (FAR) Subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Products and Commercial Services, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued.

Solicitation number 36C10G25R0037 is issued for this combined synopsis/solicitation; this solicitation is being issued as a Request for Proposal (RFP). This combined synopsis/solicitation incorporates provisions and clauses in effect through Federal Acquisition Circular (FAC) 2025-03 dated January 17, 2025.

Requirement Description:

The Veterans Health Administration (VHA) Equipment Life Cycle Management (ELCM) Program identified Multitherapy Systems: Neuromuscular Stimulator-Ultrasound Therapy System as a candidate for a VA-wide (otherwise referred to as “national”) single award Requirements contract.

Multitherapy Systems: Neuromuscular Stimulator-Ultrasound Therapy System are designed to provide therapeutic treatments by means of several modules of different external energy sources, making possible a variety of external treatments. These systems usually consist of a central control unit and modular or integral sources of energy. The system may also include a common display and software using several protocols according to the therapy to be performed. These systems are used for the application of energy from one or more sources to the patient during a variety of procedures performed during treatment. Systems that include neuromuscular stimulator as an integral part of a therapeutic ultrasound unit are used to produce a rhythmic contraction/release of injured muscles. The contraction-release acts as a pump and promotes the removal of metabolic by-products, which helps reduce spasm and pain. An electronic generator transmits pulses of energy through an active electrode or stimulator pads. Pulse waveforms are used in conjunction with ultrasound therapy. Neuromuscular stimulation combined with ultrasound therapy is used to prevent scar tissue formation in healing tissues and in identifying particular muscle trigger points to focus therapy to help reduce spasms and pain. These systems are used mainly in Physical Therapy applications located at VA Facilities Nationwide.

A single award Requirements contract will be awarded IAW FAR 52.211-6, Brand Name or Equal, in accordance with all terms, conditions, provisions, specifications, and schedule of this solicitation herein. Vendors shall contain the terms for price/cost and technical capabilities of the brand name or equal equipment. The Government reserves the right to award without discussions.

The associated North American Industrial Classification System (NAICS) code for this procurement is 334510 – Electromedical and Electrotherapeutic Apparatus Manufacturing: 6515 – Medical and Surgical Instruments, Equipment, and Supplies and the associated size standard is 1,250 employees. A nonmanufacturer rule class waiver is in effect for NAICS 334510 and applies to this requirement. This procurement action is issued as a SDVOSB set-aside.

This acquisition is for a single award Requirements contract in accordance with FAR Subpart 16.5 for Multitherapy systems and related equipment and accessories as identified in ATTACHMENT A – PRICE COST SCHEDULE - NX EQ MULTITHERAPY SYSTEMS. All interested companies shall provide a proposal for all Contract Line-Item Numbers (CLINs) listed in ATTACHMENT A – PRICE COST SCHEDULE - NX EQ MULTITHERAPY SYSTEMS.

The ordering period is for one 12-month base year with four 12-month option years. Delivery is FOB destination. Firm-Fixed Price Orders will be placed against this contract in writing and will provide the delivery locations, delivery dates and exact quantities.

After receipt of Order (ARO) is # days.

The FAR provision at 52.212-1, Instructions to Offerors – Commercial Products and Commercial Services, applies to this acquisition including attached addenda (Attachment D) to the provision.

The FAR provision at 52.212-2, Evaluation -- Commercial Products and Commercial Services, and the specific evaluation criteria as attached addenda (Attachment D) also applies to this acquisition.

The Offeror is to include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications -- Commercial Products and Commercial Services, with its offer.

Clause at 52.212-4, Contract Terms and Conditions -- Commercial Products and Commercial Services, applies to this acquisition and a statement regarding any addenda to the clause.

Clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Products and Commercial Services, applies to this acquisition and a statement regarding which, if any, of the additional FAR clauses cited in the clause are applicable to the acquisition.

An Offeror is required to be registered in SAM when submitting an offer and shall continue to be registered until time of award, during performance, and through final payment of any contract. You may access SAM at https://sam.gov/SAM/.

Questions regarding this combined synopsis/solicitation are due via email by 1200 PM ET on May 27 , 2025, to Contract Specialist/Contracting Officer, Kristal Hall at kristal.hall@va.gov. No calls will be accepted.

Offers are due via email by 1200 PM ET on June 11, 2025, to Contract Specialist/ Contracting Officer, Kristal Hall at kristal.hall@va.gov.

1. SCOPE OF WORK

The Veterans Health Administration (VHA) Equipment Life Cycle Management (ELCM) Program identified Multitherapy Systems: Neuromuscular Stimulator-Ultrasound Therapy System as a candidate for a VA-wide (otherwise referred to as “national”) single award Requirements contract.

Multitherapy Systems: Neuromuscular Stimulator-Ultrasound Therapy System are designed to provide therapeutic treatments by means of several modules of different external energy sources, making possible a variety of external treatments. These systems usually consist of a central control unit and modular or integral sources of energy. The system may also include a common display and software using several protocols according to the therapy to be performed. These systems are used for the application of energy from one or more sources to the patient during a variety of procedures performed during treatment. Systems that include neuromuscular stimulator as an integral part of a therapeutic ultrasound unit are used to produce a rhythmic contraction/release of injured muscles. The contraction-release acts as a pump and promotes the removal of metabolic by-products, which helps reduce spasm and pain. An electronic generator transmits pulses of energy through an active electrode or stimulator pads. Pulse waveforms are used in conjunction with ultrasound therapy. Neuromuscular stimulation combined with ultrasound therapy is used to prevent scar tissue formation in healing tissues and in identifying particular muscle trigger points to focus therapy to help reduce spasms and pain. These systems are used mainly in Physical Therapy applications. The Contractor must demonstrate the ability to meet all requirements for the solicitation. The objective is to provide Washer/Decontamination Units to be used by clinicians throughout the VA medical centers and facilities.

2. REQUIREMENT

This requirement will be IAW FAR 52.211-6, Brand Name or Equal, which requires the Offeror to indicate that each product is being offered as an “equal” product to the Multitherapy Systems. For each equal product, the Offeror must include a description reflecting the salient characteristics (SC) and level of quality that will satisfy the salient physical, functional, or performance characteristics of the equal product(s) specified in the solicitation. The Offeror must also clearly identify the item by brand name (if any) and make/model number. Finally, the Offeror must include descriptive literature, such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer, and clearly describe any modifications it plans to make to a product to make it conform to the solicitation requirements.

The Department of Veterans Affairs (VA) is seeking Vendors who can provide Enovis Vectra Neo Brand Name or Equal (BNOE) Multitherapy Systems as listed above or equal commodities which meet all the following salient characteristics.

CLIN’s 0001-0005 apply to the following SC’s.

DOCUMENT

TITLE

PAGE #

SC 1

CLIN 0001

CLIN 0002

SC 2

CLIN 0001

CLIN 0002

SC 3

SC 4

SC 5

SC 6

In addition to meeting the Salient Characteristics the following sub factors will be evaluated:

· Design All design features and functions of the device may be evaluated. Areas may include but are not limited to the following:

· Ease of cleaning

· Ease of transport

· Performance Device will be evaluated for its ability to perform its intended function. Areas may include but are not limited to:

· Ease of operation

· Availability of extra features, additional modalities

· Quality All aspect of the construction and quality of material of the device may be evaluated and may include but not limited to:

· Quality and durability

· Life Span

· Warranty

Vendors may offer any product solution or configuration so long as they meet the salient characteristics. Products offered in the technical volume must be captured on the Vendor’s pricing volume (Attachment A, Price Cost Schedule) of the solicitation. Vendors may offer any additional ancillary products which they deem to be essential to the functionality of the proposed solution; these items must be captured in the Vendor’s pricing volume with a quantity of zero.

The following attachments are incorporated by reference. All criteria outlined in the attachments are applicable to this combined synopsis/solicitation.

See attached document: ATTACHMENT A - PRICE COST SCHEDULE - NX EQ MULTITHERAPY SYSTEMS.

See attached document: ATTACHMENT B- CONTRACT ADMINISTRATION - NX EQ MULTITHERAPY SYSTEMS.

See attached document: ATTACHMENT C- CONTRACT CLAUSES - MULTITHERAPY SYSTEMS.

See attached document: ATTACHMENT D - SOLICITATION PROVISIONS - MULTITHERAPY SYSTEMS.

See attached document: ATTACHMENT E - REPORTING TOOL - NX EQ MULTITHERAPY SYSTEMS.

See attached document: ATTACHMENT F - PAST PERFORMANCE REFERENCE MULTITHERAPY SYSTEMS.

See attached document: ATTACHMENT G - PAST PERFORMANCE QUESTIONNAIRE - MULTITHERAPY SYSTEMS.

Page 1 of

Page 1 of Page 1 of Page 1 of